XOLAIR
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90794955
- Registration number
- 8023775
- Mark type
- Design + words
- Filed
- 25 Jun 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 11 Nov 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of chronic rhino sinusitis with nasal polyps
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jun 2025 — USE AMENDMENT FILED
- 19 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 5 GRANTED
- 17 Dec 2024 — SOU EXTENSION 5 FILED
- 01 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2024 — SOU EXTENSION 4 GRANTED
- 18 Jun 2024 — SOU EXTENSION 4 FILED